Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

The top 25 US heart hospitals | Outcomes in urban vs. rural areas | TAVR protocol boosts care | Why soda is so 'problematic'

News You Need to Know Today
The top 25 US heart hospitals | Outcomes in urban vs. rural areas | TAVR protocol boosts care | Why soda is so 'problematic'
Tuesday, June 3, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

The top 25 heart hospitals in the United States

Newsweek and Statista have crunched the data and ranked the top U.S. hospitals for cardiac care. Did your facility make the cut? 

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

The top 25 heart hospitals in the United States

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Newsweek and Statista have crunched the data and ranked the top U.S. hospitals for cardiac care. Did your facility make the cut? 
READ MORE >

Death from heart disease more common in rural areas—what can cardiologists do?

Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.

READ MORE >
Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, Explains a report showing socioeconomic factors are driving increased cardiovascular death rates, especially in younger adults, and urges action to address these health disparities.
Share on Twitter Share on Facebook Share on Linkedin

Death from heart disease more common in rural areas—what can cardiologists do?

Share on Twitter Share on Facebook Share on Linkedin
Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, Explains a report showing socioeconomic factors are driving increased cardiovascular death rates, especially in younger adults, and urges action to address these health disparities.
Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.
READ MORE >

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.
READ MORE >

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.

READ MORE >
soda soft drink coke
Share on Twitter Share on Facebook Share on Linkedin

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

Share on Twitter Share on Facebook Share on Linkedin
soda soft drink coke
“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.
READ MORE >

Featured Articles

New-look peripheral stent with expandable spikes receives FDA’s de novo classification

California-based Reflow Medical gained the approval after submitting data from the DEEPER REVEAL clinical trial. The device was associated with a high success rate and improved outcomes in CLTI patients.

READ MORE >
Reflow Medical Spur Peripheral Retrievable Stent System. Reflow Medical, a California-based medtech company focused on cardiovascular disease treatments, has received the FDA’s de novo classification for its Spur Peripheral Retrievable Stent System. De novo classification represents an alternative pathway to gaining FDA approval when no comparable devices are currently available.
Share on Twitter Share on Facebook Share on Linkedin

New-look peripheral stent with expandable spikes receives FDA’s de novo classification

Share on Twitter Share on Facebook Share on Linkedin
Reflow Medical Spur Peripheral Retrievable Stent System. Reflow Medical, a California-based medtech company focused on cardiovascular disease treatments, has received the FDA’s de novo classification for its Spur Peripheral Retrievable Stent System. De novo classification represents an alternative pathway to gaining FDA approval when no comparable devices are currently available.
California-based Reflow Medical gained the approval after submitting data from the DEEPER REVEAL clinical trial. The device was associated with a high success rate and improved outcomes in CLTI patients.
READ MORE >

The lack of diversity in cardiac surgery trials may be harmful to patients

Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.

READ MORE >
Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.
Share on Twitter Share on Facebook Share on Linkedin

The lack of diversity in cardiac surgery trials may be harmful to patients

Share on Twitter Share on Facebook Share on Linkedin
Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.
Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.
READ MORE >

FDA sees promise in new total artificial heart technology, granting it ‘breakthrough’ status

The device was built as a bridge to transplant for patients with end-stage heart failure. It is made of titanium and approximately the size of an adult’s fist.

READ MORE >
Surgeons in Houston have performed the world’s first successful human implant of BiVacor’s Total Artificial Heart (TAH) technology. The procedure was completed July 9, 2024, at The Texas Heart Institute at Baylor St. Luke’s Medical Center. It was part of an early feasibility study (EFS) first approved by the U.S. Food and Drug Administration (FDA) back in December 2023. BiVacor has received the FDA’s breakthrough device designation for its titanium Total Artificial Heart (TAH).
Share on Twitter Share on Facebook Share on Linkedin

FDA sees promise in new total artificial heart technology, granting it ‘breakthrough’ status

Share on Twitter Share on Facebook Share on Linkedin
Surgeons in Houston have performed the world’s first successful human implant of BiVacor’s Total Artificial Heart (TAH) technology. The procedure was completed July 9, 2024, at The Texas Heart Institute at Baylor St. Luke’s Medical Center. It was part of an early feasibility study (EFS) first approved by the U.S. Food and Drug Administration (FDA) back in December 2023. BiVacor has received the FDA’s breakthrough device designation for its titanium Total Artificial Heart (TAH).
The device was built as a bridge to transplant for patients with end-stage heart failure. It is made of titanium and approximately the size of an adult’s fist.
READ MORE >

In Case You Missed It

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

READ MORE >
robotic PCI Corindus CorPath GRX
Share on Twitter Share on Facebook Share on Linkedin

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Share on Twitter Share on Facebook Share on Linkedin
robotic PCI Corindus CorPath GRX
Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.
READ MORE >

Cardiology employment models undergoing a dramatic shift

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

READ MORE >
Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology employment models undergoing a dramatic shift

Share on Twitter Share on Facebook Share on Linkedin
Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
READ MORE >

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

READ MORE >
walk exercise support family
Share on Twitter Share on Facebook Share on Linkedin

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Share on Twitter Share on Facebook Share on Linkedin
walk exercise support family
Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.
READ MORE >

In Other News

FDA approves expanded use of 'powerful' lung imaging tool

The approval will make around 1 million more patients eligible to receive the specialized contrast, which enhances the evaluation of lung ventilation. 

READ MORE >
FDA approves expanded use of Xenoview for lung imaging
Share on Twitter Share on Facebook Share on Linkedin

FDA approves expanded use of 'powerful' lung imaging tool

Share on Twitter Share on Facebook Share on Linkedin
FDA approves expanded use of Xenoview for lung imaging
The approval will make around 1 million more patients eligible to receive the specialized contrast, which enhances the evaluation of lung ventilation. 
READ MORE >

FDA authorizes 1st AI tool to predict 5-year breast cancer risk from routine mammograms

Clairity Breast analyzes screening mammograms and can detect “subtle imaging features” correlated with long-term risk, the Boston-based company notes. 

READ MORE >
mammogram mammography breast cancer
Share on Twitter Share on Facebook Share on Linkedin

FDA authorizes 1st AI tool to predict 5-year breast cancer risk from routine mammograms

Share on Twitter Share on Facebook Share on Linkedin
mammogram mammography breast cancer
Clairity Breast analyzes screening mammograms and can detect “subtle imaging features” correlated with long-term risk, the Boston-based company notes. 
READ MORE >

Industry News

 

Biome Analytics launches groundbreaking tool to advance health equity through SDOH-driven insights

Hospitals can now measure and improve outcomes through the lens of social and economic disparities by integrating social determinants of health (SDOH) directly into their performance analytics.  
READ MORE >
 

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Predicting long-term outcomes | SCAI, ACC & STS share a message | Weight loss drug linked to key benefits
TAVR or SAVR? A closer look at those decisions | New Impella 5.5 data | First patient enrolled in massive heart failure trial
Teen's death at center of new lawsuit | Surgery outperforms GLP-1 drugs | Long-term antidepressant use & SCD
AI helps 3D imaging labs evolve | Catheters recalled over safety risk | New ways to predict TAVR outcomes
Looking Back: Cardiologist fired for speaking out | Hospital sues practice | Strokes after PFA | Energy drinks & heart disease
Surgery outperforms GLP-1 drugs | CEPDs fail to make an impact | Redo TAVR: Supra-annular vs. intra-annular valves
Week in Review: FDA clears imaging platform | Vascular device linked to deaths | GLP-1 drugs & AFib | Pacemakers recalled again

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup